ESR1 and type 2 diabetes mellitus: Premenopausal women without T2D are at a lower risk for cardiovascular disease than men without T2D of the same age, and much of this protection from cardiometabolic risk is thought to be due to the effects of estrogen, including estrogen receptor-mediated effects on lipid and glucose metabolism, endothelial function, and fat deposition (13).